J Clin Oncol. 2015 Dec 10;33(35):4176-87. doi: 10.1200/JCO.2015.63.4238. Epub 2015 Nov 2.
Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T1, de Gramont A2, Vernerey D2, Chibaudel B2, Bonnetain F2, Tijeras-Raballand A2, Scriva A2, Hickish T2, Tabernero J2, Van Laethem JL2, Banzi M2, Maartense E2, Shmueli E2, Carlsson GU2, Scheithauer W2, Papamichael D2, Möehler M2, Landolfi S2, Demetter P2, Colote S2, Tournigand C2, Louvet C2, Duval A2, Fléjou JF2, de Gramont A2.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου